OXFORD ENDOVASCULAR LIMITED
Research and experimental development on biotechnology
OXFORD ENDOVASCULAR LIMITED
Research and experimental development on biotechnology
AI Analysis
AI Analysis
Analyze director networks, ownership patterns, and company connections
Sign in to access AI-powered company analysis
Sign InCompanyTrack AI can make mistakes. Check important info.
Contact & Details
Contact
Update DetailsRegistered Address
9400 Garsington Road Oxford Business Park Oxford OX4 2HN United Kingdom
Office (Oxford Science Park)
G4 Magdalen Centre, Robert Robinson Avenue, Oxford, OX4 4GA, United Kingdom
Website
oxfordendovascular.comCredit Report
Discover OXFORD ENDOVASCULAR LIMITED's Credit Score, limit, and payment likelihood.
Mutual Companies
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Cash in Bank
£7.92M
Net Assets
£7.67M
Total Liabilities
£794.72k
Turnover
N/A
Employees
6
Debt Ratio
N/A
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Unlock 9 years of financial data
Sign up to view revenue, profit, assets and more
Funding
Fundraising & Grants
Investors (0)
No investor information available
Officers
Officers
| Status | ||
|---|---|---|
| Charles Richard Taylor | Director | Active |
| James Vincent Byrne | Director | Active |
| Martin Henry Diggle | Director | Active |
| Parkwalk Advisors Ltd | Corporate-director | Active |
| Pennsec Limited | Corporate-secretary | Active |
| Xie Feng | Director | Active |
Persons with Significant Control
Persons with Significant Control (1)
Parkwalk Advisors Ltd
United Kingdom
- Voting Rights 25 To 50 Percent
Oxford Sciences Innovation Plc
Ceased 30 Mar 2021
Parkwalk Advisors Ltd
Ceased 8 Feb 2024
Group Structure
Group Structure
Charges
Charges
No charges registered
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 1 Oct 2025 | Confirmation Statement | Confirmation statement made on 2025-09-09 with updates | View(6 pages) |
| 3 Jul 2025 | Accounts | Annual accounts made up to 2024-09-30 | View(13 pages) |
| 6 Jan 2025 | Capital | Allotment of shares (GBP 7,444.53) on 2025-01-02 | View(3 pages) |
| 4 Oct 2024 | Officers | Termination of Michael Karim as director on 2024-09-30 | View(1 page) |
| 16 Sept 2024 | Officers | Change to director Professor James Vincent Byrne on 2015-12-23 | View(2 pages) |
Confirmation statement made on 2025-09-09 with updates
Change to director Professor James Vincent Byrne on 2015-12-23
Recent Activity
Latest Activity
Confirmation statement made on 2025-09-09 with updates
4 months ago on 1 Oct 2025
Annual accounts made up to 2024-09-30
7 months ago on 3 Jul 2025
Allotment of shares (GBP 7,444.53) on 2025-01-02
1 years ago on 6 Jan 2025
Termination of Michael Karim as director on 2024-09-30
1 years ago on 4 Oct 2024
Change to director Professor James Vincent Byrne on 2015-12-23
1 years ago on 16 Sept 2024